Voyant Health

Software Solutions for Clinical Orthopedic Workflow

Health Tech & Life Sciences
Acquired (Inactive) by Brainlab on Jun 2011 - closed due to acquisition

Company Overview

Snapshot

Founded in June 2003, Voyant Health operated with 1–10 employees, developing technology for medical digital-imaging workflow. The company was acquired by Brainlab in June 2011.

Business overview

Voyant Health specializes in software solutions for clinical orthopedic workflow, streamlining how medical professionals manage and share digital images and related information. The company's core technology provides orthopedic surgeons with digital tools for preoperative planning and simulating surgical outcomes, particularly for joint reconstruction. Voyant Health operates within the Health Tech & Life Sciences sector, focusing on digital healthcare and clinical workflow, serving hospitals, doctors, and operating rooms.

Strategic signal

In September 2016, news highlighted that TraumaCad sales cemented Brainlab's position as the UK market leader for orthopedic surgical planning. This indicates the continued strategic value and market penetration of Voyant Health's core product, TraumaCad, years after its acquisition, signaling sustained impact and successful integration within Brainlab's portfolio.

Company Intelligence Q&A

What is Voyant Health's primary focus?
Voyant Health develops software solutions designed to streamline clinical orthopedic workflow, particularly focusing on medical digital-imaging and preoperative planning for surgeons.
When was Voyant Health acquired?
Voyant Health was acquired by Brainlab in June 2011.
What was a key product developed by Voyant Health?
A key product developed by Voyant Health is TraumaCad, which provides digital tools for orthopedic surgeons to perform preoperative planning and simulate surgical results.
Did TraumaCad receive regulatory clearance?
In November 2004, Orthocrat (Voyant Health) received FDA clearance to market its TraumaCad technology. Additionally, in March 2015, the FDA green-lighted Brainlab's TraumaCad Mobile app.
What market impact did TraumaCad have post-acquisition?
In September 2016, TraumaCad sales were noted to have cemented Brainlab's position as the UK market leader for orthopedic surgical planning, demonstrating the product's continued market relevance.

External links